: C-Rel proto-oncogene, a member of the NF-kappaB/Rel transcription factor family, plays a crucial role in regulating lymphocyte proliferation and survival processes. Dysregulation of c-Rel has been found to associate with high incidence of human diffuse large cell lymphoma. Furthermore, v-Rel over-expression in transgenic mice lead to the development of T cell leukemia and lymphomas. However, the mechanisms by which c-Ret modulates cell cycle and oncogenesis are still poorly understood. We hypothesize that Rel's oncogenic potential is linked to its ability to induce genes that are involved in cell cycle and survival, based on our preliminary studies: (1) Rel(-/-) lymphocytes have severe proliferative defects in response to antigenic and mitogenic stimuli. (2) The lack of cytokine production (e.g. IL-2 in T cells, IL-6 in B-cells) partly accounts for the proliferation defects of Rel(-/-) lymphocytes. (3) Rel(-/-) B-cells have reduced cyclin D2, D3, and E induction, impaired CDK kinase activation, and reduced E2F expression. We propose that c-Rel synergizes with cytokines in the regulation of several cell cycle events: including the induction of cyclin Ds, expression of E2F4, and activation of CDK kinases. The following aims will be investigated:
Aim 1 : To determine which cell cycle genes are directly regulated by c-Rel and/or cytokines.
Aim 2 : To determine whether any cell cycle progression events are regulated post-transcriptionally by c-Ret and/or cytokine.
Aim 3 : To determine whether c-Rel-regulated survival and cell cycle genes can cooperate to induce cell transformation in vitro and in vivo. Our studies will advance the understanding of lymphocyte cell cycle progression as well as the mechanisms of oncogenesis and eventually facilitate the identification of potential targets for the treatment of immunodeficiency, lymphomagenesis, chronic inflammation, and/or autoimmunity.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Immunobiology Study Section (IMB)
Program Officer
Mufson, R Allan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Tian, Wenzhi; Liou, Hsiou-Chi (2009) RNAi-mediated c-Rel silencing leads to apoptosis of B cell tumor cells and suppresses antigenic immune response in vivo. PLoS One 4:e5028
Cheng, Shuhua; Hsia, Constance Yu; Leone, Gustavo et al. (2003) Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel-/- B cells. Oncogene 22:8472-86
Tumang, Joseph R; Hsia, Constance Y; Tian, Wenzhi et al. (2002) IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2. Cell Immunol 217:47-57
Hsia, Constance Y; Cheng, Shuhua; Owyang, Alexander M et al. (2002) c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 14:905-16